Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 59/100

Termination Rate

19.0%

4 terminated out of 21 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

5%

1 trials in Phase 3/4

Results Transparency

40%

4 of 10 completed with results

Key Signals

4 with results71% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (6)
Early P 1 (1)
P 1 (2)
P 2 (9)
P 3 (1)

Trial Status

Completed10
Terminated4
Recruiting4
Unknown2
Not Yet Recruiting1

Trial Success Rate

71.4%

Benchmark: 86.5%

Based on 10 completed trials

Clinical Trials (21)

Showing 20 of 20 trials
NCT06231537Not ApplicableCompletedPrimary

Visual Oral Examination for Early Detection of Oral Cancer in High-Risk Individuals

NCT07401641Not ApplicableRecruiting

Effect of Dezocine Versus Nalbuphine Combined With Sufentanil on Postoperative Analgesia, Complications, and Free Flap Survival in Patients Undergoing Oral Cancer Radical Surgery: A Randomized Controlled Clinical Trial.

NCT00341497Completed

Biomarkers for Oral Cancer

NCT05774483Not ApplicableRecruitingPrimary

Sentinel Node Biopsy Versus Limited Elective Neck Dissection in Early Cancers of Oral Cavity NoDe Negative

NCT06848439Phase 2Not Yet RecruitingPrimary

Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer

NCT02285543Phase 2TerminatedPrimary

A Phase II Trial of TPF Induction Chemotherapy in cN2 OSCC Patients

NCT02290145Phase 2RecruitingPrimary

Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage

NCT05296941Not ApplicableRecruitingPrimary

Oral Cancer Screening for Early Detection of Premalignant Disorders (PMOD)

NCT02285530Phase 2UnknownPrimary

GDF15 Based TPF Induction Chemotherapy for OSCC Patients

NCT04009811Not ApplicableCompletedPrimary

A New Membrane Obturator Prothesis Concept for Soft Palate Defects

NCT00721799Phase 2CompletedPrimary

F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients

NCT02604121Not ApplicableCompletedPrimary

Cytological Screening for Early Diagnosis of Precancerous or Cancerous Lesions of Oral Cavity

NCT01216020Phase 2Terminated

Cetuximab Plus Radiotherapy Versus Cisplatin Plus Radiotherapy in Locally Advanced Head and Neck Cancer

NCT01195922Phase 1CompletedPrimary

Rapamycin Therapy in Head and Neck Squamous Cell Carcinoma

NCT00953849Phase 1CompletedPrimary

Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity

NCT01553851Phase 2Completed

GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell Cancer

NCT00412776Phase 2Terminated

Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer

NCT00272181Phase 2Terminated

Study of Proxinium for Treating Patients With Squamous Cell Head and Neck Cancer

NCT01104714Completed

Pharmacogenetic Response to Chemotherapy Induction for ORL Cancers

NCT01649349Early Phase 1Completed

The Feasibility Study of Dual-Section Nasogastric Tube

Scroll to load more

Research Network

Activity Timeline